Skip Nav Destination
ERRATUM|
November 24, 2022
Collins PJ, Fox CP, George L, et al. Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells. Blood. 2021;137(2):203-215.
Blood (2022) 140 (21): 2306.
Connected Content
This is a related article to:
Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells
Citation
Collins PJ, Fox CP, George L, et al. Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells. Blood. 2021;137(2):203-215.. Blood 2022; 140 (21): 2306. doi: https://doi.org/10.1182/blood.2021013012
Download citation file:
November 24 2022
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal